company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4639000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4639000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12805000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5894000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3291000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9185000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,28000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,48000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3668000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,235000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.18
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.18
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1574800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2011.0,FY,2011-01-01,2011-12-31,2014-02-21 15:03:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.18
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5206000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5206000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1265000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1265000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3941000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1411000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,709000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2120000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1821000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-88000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-108000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1713000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,173000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.98
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1574600000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18380000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18380000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13872000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4989000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3066000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8055000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5817000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-84000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-92000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5725000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,450000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.35
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.35
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1574600000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 15:18:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.35
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3243000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3243000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9931000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3578000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2357000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5935000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3996000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4012000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,277000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.37
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.37
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1569300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.37
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1014000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1014000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3494000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1085000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,813000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1898000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1604000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.01
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.01
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1569300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:57:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.01
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8666000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8666000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2229000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2229000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6437000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2493000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1544000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4037000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2400000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2408000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,258000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1583800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4493000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4493000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1073000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1073000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3420000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1246000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,752000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1422000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1402000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,135000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.8
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.8
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1583800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 14:48:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.8
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4173000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4173000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1156000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1156000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3017000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1247000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,792000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2039000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,978000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1006000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,883000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,883000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,883000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1577000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1576800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:53:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18790000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18790000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4581000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4581000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14209000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5352000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3193000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8545000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5664000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-278000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-54000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-332000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5332000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1204000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.58
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1604000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.56
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1600000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.58
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 12:32:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5111000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5111000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1282000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1282000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3829000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1448000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,846000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2294000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1535000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-68000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-28000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-96000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1439000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,311000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1604000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1600000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13679000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13679000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3299000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3299000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10380000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3904000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2347000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6251000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4129000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-210000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-236000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3893000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,893000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3000000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3000000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3000000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1590000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.88
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1605000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.86
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1606700000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.88
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3YTD,2013-01-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18885000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18885000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4564000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4564000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14321000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5315000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3056000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8371000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5950000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-298000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-46000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-344000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5606000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1066000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4540000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1590000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.86
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1605000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.84
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1606700000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.86
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4658000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4658000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1092000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1092000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3566000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1261000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,934000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2195000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1371000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-69000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-85000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1286000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,322000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1590000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1605000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1606700000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:09:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9021000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9021000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2207000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2207000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6814000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2643000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1413000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4056000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2758000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-141000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-151000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2607000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,571000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2036000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2036000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2036000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1609000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.2
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18735000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4486000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4486000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14249000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5139000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2935000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8074000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6175000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-228000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-251000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5924000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,763000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5161000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5161000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5161000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1609000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.25
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.2
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4692000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4692000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1054000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1054000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1406000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,779000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2185000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1453000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-75000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-85000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1368000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,300000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1068000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1068000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1068000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1609000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 17:03:44+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18536000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18536000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14031000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4979000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2908000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7887000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-151000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-186000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1588000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.4
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1605000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.39
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1586900000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.4
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4329000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4329000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1153000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3176000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1237000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,634000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1871000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-66000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-66000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,968000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,968000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,968000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1588000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1605000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1586900000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 14:11:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19960000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19960000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4426000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4426000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15534000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8474000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3649000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12123000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3411000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-651000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1042000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2369000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.1
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1598200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 12:19:05+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.75
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5452000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5452000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1119000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4333000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3841000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,907000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4748000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-129000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-493000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-622000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1037000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-227000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1598200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.49
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5019000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5019000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1094000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1094000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3925000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1845000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1120000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2965000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,960000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-145000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-273000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,181000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,506000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,506000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,506000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1581300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 13:40:18+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14508000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3307000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11201000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4633000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2742000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7375000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-262000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-158000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-420000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3406000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,822000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2584000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.62
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1581300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.62
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3YTD,2014-01-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.26
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19619000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19619000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15030000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3588000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9669000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5361000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-330000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-186000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-516000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4845000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1133000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3712000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3712000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3712000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.32
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.3
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1581300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.32
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.66
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9489000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9489000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2213000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2213000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7276000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2788000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1622000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2866000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-147000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2719000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,641000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2078000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1608000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.29
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1591300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2YTD,2014-01-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.84
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19258000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19258000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4587000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4587000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14671000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5497000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3402000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8899000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5772000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-328000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1274000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4170000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4170000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4170000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1608000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.59
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1591300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.6
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.64
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4926000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4926000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1113000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1113000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3813000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1448000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,850000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2298000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-69000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-82000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,335000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1098000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1098000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1098000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1594000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1608000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1591300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:58:41+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19024000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19024000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4528000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4528000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14496000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3331000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8786000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5710000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-277000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-54000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-331000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5379000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.58
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1609000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.57
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1606600000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.58
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.62
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4563000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1100000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3463000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1340000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,772000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2112000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1351000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-65000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-65000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1286000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,306000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1609000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1606600000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:15:17+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22859000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22859000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18359000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4435000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10822000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7537000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-686000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-206000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-892000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6645000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1501000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.15
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1637000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.13
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.15
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 12:40:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.1
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6400000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6400000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1475000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1475000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4925000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1737000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1075000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2812000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2113000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-199000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-189000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1924000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,407000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1517000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1637000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5944000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5944000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1167000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1167000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4777000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1474000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1418000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2892000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1885000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-41000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-238000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1647000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,408000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1239000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1664000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 12:52:37+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16459000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16459000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3025000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3025000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13434000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4650000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5424000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-487000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-216000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-703000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4721000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1094000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3627000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3627000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3627000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.23
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1664000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.2
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.23
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3YTD,2015-01-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.53
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21911000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21911000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17767000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8491000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4267000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12758000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5009000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-709000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1325000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3684000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,867000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2817000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2817000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2817000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.72
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1664000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.7
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.72
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5475000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5475000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,916000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,916000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4559000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1703000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1004000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2707000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1852000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-164000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1678000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,312000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1366000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1626200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 12:24:41+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1858000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1858000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8657000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3176000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3539000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-290000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-175000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-465000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3074000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,686000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2388000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.48
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.46
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1626200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.48
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2YTD,2015-01-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20986000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4071000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4071000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16915000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8862000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3969000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12831000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4084000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-547000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-813000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2724000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2084000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2084000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2084000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1620000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.29
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1626200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.29
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.93
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5040000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5040000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4098000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1473000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,938000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2411000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-126000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-165000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-291000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1396000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,374000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.64
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1608000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1596900000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.64
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 12:22:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20437000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20437000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16169000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8607000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3815000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12422000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-452000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2479000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,663000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1816000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1608000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.12
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1596900000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.84
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25638000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5832000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19806000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5881000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4585000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10466000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9340000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-965000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-491000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1456000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1931000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5953000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5953000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5953000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1622000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.65
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.63
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.65
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 16:45:37+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.35
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6796000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6796000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1554000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1554000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5242000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1679000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1249000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2314000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-290000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-316000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1998000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,607000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1391000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1622000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.86
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.64
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6432000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6432000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1504000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1186000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2567000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2361000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-250000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-97000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-347000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2014000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,416000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1598000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.97
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1647400000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.97
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 11:27:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18842000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18842000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4278000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4278000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14564000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4202000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3336000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7538000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7026000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-675000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-465000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1140000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5886000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1324000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.79
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.78
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1647400000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.79
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3YTD,2016-01-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.71
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25242000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25242000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19489000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5939000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4411000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10350000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9139000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-874000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1329000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7810000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1731000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.71
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1640000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.71
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1647400000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.71
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.28
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6452000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6452000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1405000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1405000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5047000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1466000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1194000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2660000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-225000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-66000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-291000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2096000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,486000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1610000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.99
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.98
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1626300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.99
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 12:15:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2774000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9636000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2821000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2150000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4971000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4665000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-425000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-368000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-793000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3872000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,908000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2964000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.82
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1626300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.82
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2YTD,2016-01-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24754000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24754000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5416000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5416000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19338000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6032000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4643000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10675000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8663000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-821000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-399000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1220000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7443000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1723000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.49
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.48
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1626300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.49
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.22
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1369000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1369000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1355000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,956000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2311000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2278000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-200000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-302000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-502000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1776000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,422000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1354000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1354000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1354000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1631300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 10:09:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23777000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23777000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4927000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4927000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18850000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6269000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4453000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10722000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-760000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-343000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1103000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7025000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1549000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5476000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5476000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5476000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.34
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1625000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.33
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1631300000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.34
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.16
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28216000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28216000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7042000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7042000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21174000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6295000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5334000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11629000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9545000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1004000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-814000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1818000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7727000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2418000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5309000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5309000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5309000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.31
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.3
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1603900000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.31
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 10:51:26+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.63
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7739000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7739000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2281000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2281000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5458000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1956000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1720000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3676000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1782000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-252000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-337000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-589000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1193000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1141000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1603900000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.35
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6995000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6995000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5379000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1457000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1228000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2685000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2694000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-252000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-347000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-599000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2095000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,464000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1631000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.01
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1599000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 12:45:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4761000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4761000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15716000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4339000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3614000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7953000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7763000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-752000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-477000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1229000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6534000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1277000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5257000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5257000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5257000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.29
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.26
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1599000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.29
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.28
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27273000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27273000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6315000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6315000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6018000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4863000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10881000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10077000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1042000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-503000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1545000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8532000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6648000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6648000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6648000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.15
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.11
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1599000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.15
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.92
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6944000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6944000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1529000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1529000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5415000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1509000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1244000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2662000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-253000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-56000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-309000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2353000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,438000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1915000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1915000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1915000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.2
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1600000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.19
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1595800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.2
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 13:14:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.64
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13482000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13482000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3145000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3145000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10337000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2386000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5268000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5069000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-130000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-630000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4439000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,813000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3626000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1600000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.25
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1595800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.28
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26710000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26710000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6203000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6203000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20507000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4821000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10763000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9744000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1040000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-253000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1293000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8451000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1836000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6615000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6615000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6615000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.1
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1600000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.07
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1595800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.1
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.49
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6538000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6538000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4922000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1373000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1142000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2407000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-247000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-74000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-321000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2086000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,375000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1711000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1711000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1711000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.07
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1599100000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.07
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 10:56:33+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.64
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6079000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20139000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5899000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4771000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10670000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9469000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1012000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-263000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1275000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8194000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6310000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6310000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6310000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1597000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.89
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.86
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1599100000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.89
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.42
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7718000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7718000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25035000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7399000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10753000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18652000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6383000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1144000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-42000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1186000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-490000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.67
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1546000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.66
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1549600000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.67
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 10:51:26+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.95
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8305000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2022000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6283000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1429000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6795000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8724000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2441000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-319000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,387000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,68000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2373000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-547000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1541000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1546000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1549600000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.95
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8236000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8236000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1835000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1835000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6401000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1919000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1323000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3242000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3159000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-302000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-96000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-398000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2761000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2747000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1517700000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 10:16:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24448000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24448000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5696000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18752000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5970000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3958000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9928000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8824000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-825000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-429000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1254000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7570000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1517700000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32187000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32187000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7977000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7977000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24210000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7926000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5678000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13604000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10606000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1077000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-766000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1843000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8763000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1198000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7565000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7565000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7565000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1511000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.83
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1515000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.85
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1517700000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.83
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.35
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8278000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8278000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1934000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1934000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6344000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2260000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1322000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3582000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2762000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-272000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-478000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-750000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2012000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1983000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1983000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1983000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1568000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1572000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1573800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 12:33:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16212000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16212000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3861000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3861000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12351000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4051000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2635000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6686000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5665000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-523000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-333000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-856000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4809000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4766000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4766000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4766000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1568000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1572000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1573800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30946000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30946000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7758000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7758000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23188000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7464000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5583000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13047000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10141000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1027000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1017000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2044000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8097000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1648000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6449000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6449000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6449000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1568000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.04
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1572000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.05
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1573800000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.04
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.35
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7934000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7934000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1927000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1927000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6007000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1791000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1313000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3104000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2903000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-251000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,145000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-106000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2797000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2783000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1591000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.74
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.74
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1599400000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 10:28:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.74
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29612000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29612000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7353000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7353000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22259000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6713000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10041000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1008000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-595000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8438000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2057000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6381000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1591000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.98
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.98
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1599400000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.98
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.99
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8704000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8704000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2006000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2006000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6698000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1951000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1681000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-890000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2742000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3956000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-427000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3074000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,273000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2801000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2801000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2801000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.89
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.88
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1487200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.89
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.39
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33266000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33266000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7439000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7439000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25827000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6792000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-890000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12844000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12983000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1509000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3048000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4557000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8426000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,544000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7882000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.3
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.28
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1487200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.3
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 10:51:26+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.39
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24562000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5433000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19129000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4991000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5111000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10102000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9027000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1054000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2621000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3675000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5352000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,271000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5081000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.41
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.4
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1483500000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.41
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32867000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32867000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7455000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25412000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6420000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11906000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6586000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1373000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2234000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3607000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2979000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-276000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.25
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1483500000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.95
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8479000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8479000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1920000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1920000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6559000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1657000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2285000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2617000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-420000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-196000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-616000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2001000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,117000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1483500000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 10:16:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16083000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16083000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3513000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12570000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3334000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2826000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6160000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6410000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-634000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2425000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3059000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3351000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,154000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3197000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1512200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.14
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32624000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7370000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7370000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25254000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6682000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10944000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18126000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7128000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3389000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3739000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-379000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4118000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.8
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1512200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.81
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.95
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8255000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1819000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1819000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1654000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1382000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3036000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3400000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-309000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2284000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2593000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,807000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,66000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,741000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,741000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,741000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1512200000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 12:33:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7828000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7828000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1694000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1694000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6134000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1680000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1444000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3124000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-325000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-141000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-466000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2544000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,88000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2456000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2456000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2456000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.65
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1488500000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 19:19:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.65
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32647000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32647000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7485000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7485000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25162000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7288000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10884000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18672000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6490000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1218000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-328000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1546000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4944000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-416000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5360000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1480000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.58
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1483000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.57
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1488500000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.58
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.95
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34057000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34057000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7687000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26370000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6957000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6727000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-890000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12794000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13576000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1612000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2984000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4596000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8980000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,544000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8436000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.67
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.65
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1490100000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.67
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.39
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8619000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8619000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1942000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6677000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1695000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1379000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3074000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3603000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-428000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-77000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-505000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3098000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,88000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3010000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1481000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1484000000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.02
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1490100000.0
AbbVie Inc,ABBV,FR5LCKFTG8054YNNRU85,0001551152,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 19:19:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.02
